John Levy

Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells

John Levy, Rebecca R. Muldoon, Sergei Zolotukhin et al. · Nature Biotechnology · 1996 · 97 citations

Human Tumor Cells, Cancer-associated Virus, Medicine +9

Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells

Frederick E. Domann, John Levy, Joanne S. Finch et al. · Molecular Carcinogenesis · 1994 · 71 citations

First clinical experience using a ‘pathotropic’ injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer

Erlinda M. Gordon, Gerardo Cornelio, Conrado Lorenzo et al. · International Journal of Oncology · 2004 · 56 citations

Translational Medicine, Surgical Oncology, Gene Therapies +14

A Phase I Trial of <i>In Vivo</i> Gene Therapy with the Herpes Simplex Thymidine Kinase/Ganciclovir System for the Treatment of Refractory or Recurrent Ovarian Cancer. Iowa Methodist Medical Center, Des Moines, Iowa

Charles J. Link, Donald W. Moorman, Tatiana Seregina et al. · Human Gene Therapy · 1996 · 45 citations

In Vivo Gene Therapy, Gynecology, Pathology +22

Tracking and Quantitation of Retroviral-Mediated Transfer Using a Completely Humanized, Red-Shifted Green Fluorescent Protein Gene

Rebecca R. Muldoon, John Levy, Steven R. Kain et al. · BioTechniques · 1997 · 42 citations · Full text

Viral Replication, Gfp Gene, Signal Transduction +14